| abstract |
The present application discloses compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases such as cancer. The application also discloses pharmaceutical compositions containing such compounds and methods of treating cancer using the compounds and compositions of the invention. |